Retrospective Study of Brachytherapy

A Retrospective Study of Brachytherapy in Gynecological Cancers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05242861

Acronym

RetroBT

Enrollment

300

Registered

2022-02-16

Start date

2022-02-20

Completion date

2027-12-31

Last updated

2022-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brachytherapy, Gynecologic Neoplasm, Ovarian Neoplasms, Uterine Cervical Neoplasms, Uterine Neoplasms, Vaginal Cancer, Vulvar Cancer

Keywords

Brachytherapy, Cervical Cancer, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Image Guided, 3D Print

Brief summary

Brachytherapy for gynecological cancers will be studied retrospectively.

Interventions

RADIATIONBrachytherapy

Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* 18 - 80 female * Underwent brachytherapy * With gynecological cancer

Exclusion criteria

* Refusal to enter this trial

Design outcomes

Primary

Measure	Time frame	Description
Overall survival rate	5-year	the percentage of participants in the group who survives

Secondary

Measure	Time frame	Description
Progression-free survival rate	5-year	the percentage of participants in the group whose disease is likely to remain stable
Side effects	5-year	side effects associated with treatment

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026